CoChat

Blood-based immune-endocrine biomarkers of treatment response in depression

Open access
Chan, Man K., Cooper, Jason D., Bot, Mariska, Birkenhager, Tom K., Bergink, Veerle, Drexhage, Hemmo A., Steiner, Johann, Rothermundt, Matthias, Penninx, Brenda W.J.H., Bahn, Sabine · 2016 · Journal of Psychiatric Research
Cited by 36

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Antidepressant treatment for major depressive disorder remains suboptimal with response rates of just over 50%. Although treatment guidelines, algorithms and clinical keys are available to assist the clinician, the process of finding an effective pharmacotherapy to maximise benefit for the individual patient is largely by "trial and error" and remains challenging. This highlights a clear need to identify biomarkers of treatment response to help guide personalised treatment strategies. We have carried out the largest multiplex immunoassay based longitudinal study to date, examining up to 258 serum markers involved in immune, endocrine and metabolic processes as potential biomarkers associated with treatment response in 332 depression patients recruited from four independent clinical centres. We demonstrated for the first time that circulating Apolipoprotein A-IV, Endoglin, Intercellular Adhesion Molecule 1, Tissue Inhibitor of Metalloproteinases 1, Plasminogen Activator Inhibitor 1, Thrombopoietin, Complement C3, Hepatocyte Growth Factor and Insulin-like Growth Factor-Binding Protein 2 were associated with response to different antidepressants. In addition, we showed that specific sets of immune-endocrine proteins were associated with response to Venlafaxine (serotonin-norepinephrine reuptake inhibitor), Imipramine (tricyclic antidepressant) and other antidepressant drugs. However, we were not able to reproduce the literature findings on BDNF and TNF-α, two of the most commonly reported candidate treatment response markers. Despite the need for extensive validation studies, our preliminary findings suggest that a pre-treatment immune-endocrine profile may help to determine a patient's likelihood to respond to specific antidepressant and/or alternative treatments such as anti-inflammatory drugs, providing hope for future personalised treatment approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpsychires.2016.08.020

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 36

Metadata

Authors
Chan, M. K., Cooper, J. D., Bot, M., Birkenhager, T. K., Bergink, V., Drexhage, H. A., Steiner, J., Rothermundt, M., Penninx, B. W. J. H., & Bahn, S.
Venue
Journal of Psychiatric Research
Publisher
Elsevier BV
Published
2016-12
Volume
83
Pages
249-259
ISSN
0022-3956 (ISSN-L)
OpenAlex
W2517553625
Cited by
36
References
16
FWCI
1.82
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood-based immune-endocrine biomarkers of treatment response in depression. https://app.cochat.ai/papers/10.1016/j.jpsychires.2016.08.020
The paper
Chan, M. K., Cooper, J. D., Bot, M., Birkenhager, T. K., Bergink, V., Drexhage, H. A., Steiner, J., Rothermundt, M., Penninx, B. W. J. H., & Bahn, S. (2016). Blood-based immune-endocrine biomarkers of treatment response in depression. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2016.08.020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.